This event has been treated in (b)(6).As an incidence ((b)(4)).We have been notified that one dosi-fuser unit had overinfusion during a 5-fu treatment on a patient, in the conditions and outcomes related in block b.5.The defective unit was not returned to us, therefore we can't perform an exhaustive evaluation on a patient, in the conditions and outcomes related.The defective unit was not returned to us, therefore we can't perform an exhaustive evaluation of the defect detected and we can't find out the possible causes of this product behavior.The batch record of the involved lot number was reviewed and no incidence similar to the reported one was detected in the controls done during the manufacturing process nor in the control done before product release.None of the evaluated units showed any kind of defect.Three retained units of the same lot number were tested, with positive results.Therefore, we have not been able to reproduce the defect detected by the customer.We consider that the defective unit could have been affected by some of the external factors that can modify the infusion time (temperature and viscosity of the solution, filling volume or height of reservoir with regard to the mid-auxilliary level).
|